Minimally Invasive Glaucoma Surgery (MIGS) Devices Growth Trajectory: Key Forecasts and Strategic Insights
Discover trends, market shifts, and competitive outlooks for the minimally invasive glaucoma surgery (migs) devices industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What is the Anticipated CAGR of the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, and What Factors Will Drive It?
In recent years, the market size for minimally invasive glaucoma surgery (MIGS) devices has seen significant expansion. Its growth is projected to rise from $0.7 billion in 2024 to $0.9 billion in 2025, with a compound annual growth rate (CAGR) of 28.3%. The historic growth of this market can be traced back to factors such as heightened awareness towards curbing blindness, increased investment in healthcare infrastructure, heightened patient understanding regarding state-of-the-art vision correction treatments, as well as increased government initiatives in this area.
The market size for minimally invasive glaucoma surgery (MIGS) devices is expected to experience tremendous growth in the upcoming years, expanding to $2.42 billion by 2029 with a compound annual growth rate (CAGR) of 28.1%. Factors contributing to the growth during the forecast period include an increased occurrence of eye disorders such as glaucoma, an aging population, advancements in the healthcare infrastructure, and a rising demand for safer and more effective treatment options. Significant trends predicted for the forecast period encompass the adoption and advancement of MIGS devices, the invention of innovative minimally intrusive glaucoma surgery equipment, the development of sophisticated implantable devices, and progress made in ophthalmic technology.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15863&type=smp
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?
The escalation in the occurrence of eye disorders is projected to drive the expansion of the market for minimally invasive glaucoma surgery (MIGS) devices in the future. Eye disorders, which include a wide variety of conditions that compromise eyes and sight, are becoming more prevalent due to shifts in lifestyle, environmental factors, and an aging population. MIGS devices are groundbreaking instruments employed in tackling numerous eye diseases, primarily targeting the reduction of intraocular pressure (IOP) to hinder or manage the progression of glaucoma. For example, the National Eye Institute, a government agency based in the US, predicts that around 2.2 million Americans will either be totally or partially vision impaired by 2030. Thus, the escalating occurrence of eye disorders spurs the growth of the minimally invasive glaucoma surgery (MIGS) devices market.
Which Segments in the Minimally Invasive Glaucoma Surgery (MIGS) Devices Offer the Most Growth?
The minimally invasive glaucoma surgery (MIGS) devices market covered in this report is segmented –
1) By Product: Valves, Glaucoma Drainage Implant, Glaucoma Tube Shunts, Stents, Other Products
2) By Surgery: Glaucoma In Conjunction With Cataract, Stand Alone Glaucoma
3) By Target: Trabecular Meshwork, Suprachoroidal Space, Other Targets
4) By Distribution Channel: Direct Tender, Retail Sales
5) By End User: Ophthalmology Clinics, Ambulatory Surgery Centers (ASCS), Other End Users
Subsegments:
1) By Valves: Micro Shunt Valves, Non-penetrating Valves
2) By Glaucoma Drainage Implant: Scleral Drainage Implants, Subconjunctival Drainage Implants
3) By Glaucoma Tube Shunts: Ahmed Tube Shunt, Baerveldt Tube Shunt
4) By Stents: Ab-Interno Stents, Ab-Externo Stents
5) By Other Products: Cyclodestructive Devices, Trabecular Bypass Devices
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=15863&type=smp
Which Areas Are Leading Regions in the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Expansion Across the Globe?
North America was the largest region in the minimally invasive glaucoma surgery (MIGS) devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive glaucoma surgery (MIGS) devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Are the Most Significant Market Trends in the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?
Leading enterprises in the minimally invasive glaucoma surgery (MIGS) devices market are concentrating on creating revolutionary items like stent injectable systems to fulfill voids in glaucoma treatment and enhance patient results. A stent injectable system is a MIGS device that is implanted through an injection-like process using a specialized delivery mechanism often used in minimally invasive surgeries to treat conditions such as blocked or narrowed blood vessels. For example, in August 2022, Glaukos Corporation, an ophthalmic medical technology firm based in the US, obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the iStent Infinite Trabecular Micro-Bypass System. The iStent Infinite, an innovative three-stent injectable system, is designed to provide constant, round-the-clock intraocular pressure (IOP) management for patients suffering from primary open-angle glaucoma (POAG) who are not able to control IOP with prior medication and surgical treatment.
View the full report here:
What Are the Key Elements That Define the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?
Minimally invasive glaucoma surgery (MIGS) devices are medical instruments designed to lower intraocular pressure (IOP) in patients with glaucoma through less invasive surgical techniques compared to traditional glaucoma surgeries. These devices aim to reduce the risk of complications, shorten recovery time, and improve patient outcomes by offering a safer and less invasive option for patients needing surgical intervention to manage their condition.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15863
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
